Nashat Amir Insider Trading
Get the latest insider transactions of Nashat Amir. Nashat Amir is Director in aTYR PHARMA INC ($LIFE) and Director in BIND Therapeutics, Inc ($BIND) and Director in FATE THERAPEUTICS INC ($FATE) and Director in SELECTA BIOSCIENCES INC ($SELB) and Director in Receptos, Inc. ($RCPT) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Metacrine, Inc. ($MTCR) and Director in Morphic Holding, Inc. ($MORF) and Director in Scholar Rock Holding Corp ($SRRK). Discover the current value of Nashat Amir shares.
Address: 10835 ROAD TO THE CURE, SUITE 205 SAN DIEGO 92121CA
Nashat Amir is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
RCPT | Receptos, Inc. | Director | 1,186,940 | 275,322,602.40 |
LIFE | aTYR PHARMA INC | Director | 17,638 | 59,969.20 |
FATE | FATE THERAPEUTICS INC | Director | 1,129,554 | 3,162,751.20 |
BIND | DNIB UNWIND, INC. | Director | 0 | 0.00 |
SELB | SELECTA BIOSCIENCES INC | Director | 52,156 | 721,317.48 |
SYRS | Syros Pharmaceuticals, Inc. | Director | 1,164,486 | 12,716,187.12 |
SRRK | Scholar Rock Holding Corp | Director | 330,948 | |
MORF | Morphic Holding, Inc. | Director | 473,276 | |
MTCR | Metacrine, Inc. | Director | 214,962 |
Insider Trading Transactions of Nashat Amir
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Jun 17 2021 | MORF | Morphic Holding, Inc. | Nashat Amir | Director | Option Exercise | 64.79 | 12,000 | 777,480 | 12,000 |
Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | 13.00 | 214,962 | 2,794,506 | 214,962 |
Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | 13.00 | 15,038 | 195,494 | 15,038 |
Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | 0.00 | 1,832,582 | 0 | 2,047,544 |
Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | 0.00 | 128,201 | 0 | 143,239 |
Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | 0.00 | 451,666 | 0 | 2,499,210 |
Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | 0.00 | 20,585 | 0 | 163,824 |
Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | 0.00 | 216,106 | 0 | 2,715,316 |
Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Buy | 0.00 | 15,118 | 0 | 178,942 |
Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Option Exercise | 0.00 | 1,832,582 | 0 | 0 |
Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Option Exercise | 0.00 | 128,201 | 0 | 0 |
Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Option Exercise | 0.00 | 451,666 | 0 | 0 |
Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Option Exercise | 0.00 | 20,585 | 0 | 0 |
Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Option Exercise | 0.00 | 216,106 | 0 | 0 |
Sep 22 2020 | MTCR | Metacrine, Inc. | Nashat Amir | Director | Option Exercise | 0.00 | 15,118 | 0 | 0 |
Jun 19 2020 | MORF | Morphic Holding, Inc. | Nashat Amir | Director | Option Exercise | 22.96 | 12,000 | 275,520 | 12,000 |
Jun 18 2020 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 17.65 | 13,000 | 229,450 | 13,000 |
Jun 11 2020 | SYRS | Syros Pharmaceuticals, In ... | Nashat Amir | Director | Option Exercise | 9.17 | 17,500 | 160,475 | 17,500 |
Jun 11 2020 | SYRS | Syros Pharmaceuticals, In ... | Nashat Amir | Director | Option Exercise | 9.17 | 17,500 | 160,475 | 17,500 |
Aug 02 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.53 | 30,045 | 677,022 | 1,129,554 |
Aug 02 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.53 | 29,782 | 670,971 | 1,099,772 |
Aug 02 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.53 | 586 | 13,205 | 22,019 |
Aug 02 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.53 | 581 | 13,090 | 21,438 |
Aug 02 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.53 | 206 | 4,642 | 7,743 |
Aug 02 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.53 | 204 | 4,596 | 7,539 |
Aug 02 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.53 | 302 | 6,805 | 11,333 |
Aug 02 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.53 | 299 | 6,736 | 11,034 |
Jul 30 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.50 | 26,852 | 604,170 | 1,246,926 |
Jul 30 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.50 | 317 | 7,133 | 1,246,609 |
Jul 30 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.51 | 87,010 | 1,958,325 | 1,159,599 |
Jul 30 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.50 | 523 | 11,768 | 24,307 |
Jul 30 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.50 | 6 | 135 | 24,301 |
Jul 30 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.51 | 1,696 | 38,172 | 22,605 |
Jul 30 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.50 | 184 | 4,140 | 8,548 |
Jul 30 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.50 | 3 | 68 | 8,545 |
Jul 30 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.51 | 596 | 13,414 | 7,949 |
Jul 30 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.50 | 270 | 6,075 | 12,511 |
Jul 30 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.50 | 3 | 68 | 12,508 |
Jul 30 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.51 | 873 | 19,649 | 11,635 |
Jul 25 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.51 | 59,854 | 1,347,014 | 1,292,946 |
Jul 25 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.51 | 19,168 | 431,389 | 1,273,778 |
Jul 25 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.51 | 1,167 | 26,263 | 25,204 |
Jul 25 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.51 | 374 | 8,417 | 24,830 |
Jul 25 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.51 | 411 | 9,250 | 8,864 |
Jul 25 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.51 | 132 | 2,971 | 8,732 |
Jul 25 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.51 | 601 | 13,526 | 12,973 |
Jul 25 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.51 | 192 | 4,321 | 12,781 |
Jul 22 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.50 | 20,656 | 464,849 | 1,400,808 |
Jul 22 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.50 | 1,016 | 22,860 | 1,399,792 |
Jul 22 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.52 | 46,992 | 1,058,457 | 1,352,800 |
Jul 22 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.50 | 403 | 9,069 | 27,308 |
Jul 22 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.50 | 20 | 450 | 27,288 |
Jul 22 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.52 | 917 | 20,655 | 26,371 |
Jul 22 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.50 | 142 | 3,196 | 9,605 |
Jul 22 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.50 | 7 | 158 | 9,598 |
Jul 22 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.52 | 323 | 7,275 | 9,275 |
Jul 22 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.50 | 208 | 4,681 | 14,056 |
Jul 22 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.50 | 10 | 225 | 14,046 |
Jul 22 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 22.52 | 472 | 10,631 | 13,574 |
Jul 01 2019 | MORF | Morphic Holding, Inc. | Nashat Amir | Director | Buy | 0.00 | 473,276 | 0 | 473,276 |
Jul 01 2019 | MORF | Morphic Holding, Inc. | Nashat Amir | Director | Buy | 0.00 | 1,236,302 | 0 | 1,709,578 |
Jul 01 2019 | MORF | Morphic Holding, Inc. | Nashat Amir | Director | Buy | 0.00 | 344,662 | 0 | 2,054,240 |
Jul 01 2019 | MORF | Morphic Holding, Inc. | Nashat Amir | Director | Buy | 0.00 | 33,108 | 0 | 33,108 |
Jul 01 2019 | MORF | Morphic Holding, Inc. | Nashat Amir | Director | Buy | 0.00 | 86,487 | 0 | 119,595 |
Jul 01 2019 | MORF | Morphic Holding, Inc. | Nashat Amir | Director | Buy | 0.00 | 24,111 | 0 | 143,706 |
Jul 01 2019 | MORF | Morphic Holding, Inc. | Nashat Amir | Director | Buy | 15.00 | 116,827 | 1,752,405 | 2,171,067 |
Jul 01 2019 | MORF | Morphic Holding, Inc. | Nashat Amir | Director | Buy | 15.00 | 8,173 | 122,595 | 151,879 |
Jul 01 2019 | MORF | Morphic Holding, Inc. | Nashat Amir | Director | Option Exercise | 0.00 | 473,276 | 0 | 0 |
Jul 01 2019 | MORF | Morphic Holding, Inc. | Nashat Amir | Director | Option Exercise | 0.00 | 1,236,302 | 0 | 0 |
Jul 01 2019 | MORF | Morphic Holding, Inc. | Nashat Amir | Director | Option Exercise | 0.00 | 344,662 | 0 | 0 |
Jul 01 2019 | MORF | Morphic Holding, Inc. | Nashat Amir | Director | Option Exercise | 0.00 | 33,108 | 0 | 0 |
Jul 01 2019 | MORF | Morphic Holding, Inc. | Nashat Amir | Director | Option Exercise | 0.00 | 86,487 | 0 | 0 |
Jul 01 2019 | MORF | Morphic Holding, Inc. | Nashat Amir | Director | Option Exercise | 0.00 | 24,111 | 0 | 0 |
Jun 18 2019 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 2.10 | 10,000 | 21,000 | 10,000 |
Jun 12 2019 | SYRS | Syros Pharmaceuticals, In ... | Nashat Amir | Director | Option Exercise | 5.60 | 11,000 | 61,600 | 11,000 |
May 23 2019 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 21.21 | 10,158 | 215,451 | 10,158 |
May 07 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Option Exercise | 17.15 | 16,000 | 274,400 | 16,000 |
Feb 01 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 14.16 | 51,224 | 725,562 | 1,474,979 |
Feb 01 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 14.16 | 990 | 14,023 | 1,473,989 |
Feb 01 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 14.16 | 340 | 4,816 | 1,473,649 |
Feb 01 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 14.16 | 463 | 6,558 | 1,473,186 |
Jan 31 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 14.16 | 94,081 | 1,332,375 | 1,529,622 |
Jan 31 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 14.16 | 1,834 | 25,973 | 1,527,788 |
Jan 31 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 14.16 | 644 | 9,120 | 1,527,144 |
Jan 31 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 14.16 | 941 | 13,326 | 1,526,203 |
Jan 30 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 13.78 | 67,546 | 930,946 | 1,626,157 |
Jan 30 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 13.78 | 1,316 | 18,138 | 1,624,841 |
Jan 30 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 13.78 | 463 | 6,381 | 1,624,378 |
Jan 30 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 13.78 | 675 | 9,303 | 1,623,703 |
Jan 29 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 14.14 | 86,844 | 1,228,122 | 1,696,859 |
Jan 29 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 14.14 | 1,693 | 23,942 | 1,695,166 |
Jan 29 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 14.14 | 595 | 8,414 | 1,694,571 |
Jan 29 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 14.14 | 868 | 12,275 | 1,693,703 |
Jan 29 2019 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Buy | 1.50 | 21,941 | 32,912 | 52,156 |
Jan 29 2019 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Buy | 1.50 | 7,711 | 11,567 | 18,329 |
Jan 29 2019 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Buy | 1.50 | 11,258 | 16,887 | 26,760 |
Jan 29 2019 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Buy | 1.50 | 1,125,756 | 1,688,634 | 2,676,234 |
Jan 23 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 16.28 | 38,098 | 620,285 | 1,785,088 |
Jan 23 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 16.28 | 743 | 12,097 | 1,784,345 |
Jan 23 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 16.28 | 261 | 4,249 | 1,784,084 |
Jan 23 2019 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 16.28 | 381 | 6,203 | 1,783,703 |
Dec 26 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 12.25 | 32,300 | 395,775 | 1,824,360 |
Dec 26 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 12.25 | 630 | 7,719 | 1,823,730 |
Dec 26 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 12.25 | 221 | 2,708 | 1,823,509 |
Dec 26 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 12.25 | 323 | 3,958 | 1,823,186 |
Dec 21 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 13.21 | 64,989 | 858,362 | 1,882,881 |
Dec 21 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 13.96 | 23,023 | 321,364 | 1,859,858 |
Dec 21 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 13.20 | 1,261 | 16,651 | 1,858,597 |
Dec 21 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 13.96 | 454 | 6,337 | 1,858,143 |
Dec 21 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 13.17 | 423 | 5,569 | 1,857,720 |
Dec 21 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 13.96 | 180 | 2,513 | 1,857,540 |
Dec 21 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 13.19 | 640 | 8,445 | 1,856,900 |
Dec 21 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 13.96 | 240 | 3,351 | 1,856,660 |
Dec 17 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 16.67 | 17,164 | 286,160 | 1,948,494 |
Dec 17 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 16.67 | 334 | 5,568 | 1,948,160 |
Dec 17 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 16.67 | 118 | 1,967 | 1,948,042 |
Dec 17 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 16.67 | 172 | 2,868 | 1,947,870 |
Dec 14 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 16.78 | 410,097 | 6,882,576 | 1,980,561 |
Dec 14 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 16.78 | 7,993 | 134,145 | 1,972,568 |
Dec 14 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 16.78 | 2,809 | 47,143 | 1,969,759 |
Dec 14 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 16.78 | 4,101 | 68,826 | 1,965,658 |
Dec 13 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 16.71 | 79,634 | 1,330,820 | 2,393,552 |
Dec 13 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 16.71 | 1,552 | 25,937 | 2,392,000 |
Dec 13 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 16.71 | 546 | 9,125 | 2,391,454 |
Dec 13 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Sell | 16.71 | 796 | 13,303 | 2,390,658 |
Jun 26 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 21.62 | 20,316 | 439,232 | 20,316 |
Jun 19 2018 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 12.75 | 10,000 | 127,500 | 10,000 |
Jun 15 2018 | SYRS | Syros Pharmaceuticals, In ... | Nashat Amir | Director | Option Exercise | 12.95 | 11,000 | 142,450 | 11,000 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 330,948 | 0 | 330,948 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 19,340 | 0 | 19,340 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 493,705 | 0 | 824,653 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 28,851 | 0 | 48,191 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 479,634 | 0 | 1,304,287 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 28,028 | 0 | 76,219 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 260,670 | 0 | 1,564,957 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 15,233 | 0 | 91,452 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 693,294 | 0 | 2,258,251 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 40,514 | 0 | 131,966 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 283,090 | 0 | 2,541,341 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 16,542 | 0 | 148,508 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 14.00 | 134,970 | 1,889,580 | 2,676,311 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 14.00 | 7,887 | 110,418 | 156,395 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 944,789 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 55,211 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 1,409,429 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 82,363 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 1,369,259 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 80,016 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 744,162 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 43,487 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 1,979,216 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 115,659 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 808,166 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 47,225 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 330,948 | 0 | 330,948 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 19,340 | 0 | 19,340 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 493,705 | 0 | 824,653 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 28,851 | 0 | 48,191 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 479,634 | 0 | 1,304,287 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 28,028 | 0 | 76,219 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 260,670 | 0 | 1,564,957 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 15,233 | 0 | 91,452 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 693,294 | 0 | 2,258,251 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 40,514 | 0 | 131,966 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 283,090 | 0 | 2,541,341 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 0.00 | 16,542 | 0 | 148,508 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 14.00 | 134,970 | 1,889,580 | 2,676,311 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Buy | 14.00 | 7,887 | 110,418 | 156,395 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 944,789 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 55,211 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 1,409,429 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 82,363 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 1,369,259 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 80,016 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 744,162 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 43,487 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 1,979,216 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 115,659 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 808,166 | 0 | 0 |
May 31 2018 | SRRK | Scholar Rock Holding Corp | Nashat Amir | Director | Option Exercise | 0.00 | 47,225 | 0 | 0 |
May 17 2018 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | 1.35 | 20,000 | 27,000 | 20,000 |
May 04 2018 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Option Exercise | 9.78 | 16,000 | 156,480 | 16,000 |
Sep 28 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 18.91 | 1,321 | 24,982 | 30,215 |
Sep 28 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 18.91 | 464 | 8,775 | 10,618 |
Sep 28 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 18.91 | 677 | 12,803 | 15,502 |
Sep 28 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 18.91 | 67,764 | 1,281,519 | 1,550,478 |
Sep 26 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 19.26 | 790 | 15,218 | 32,235 |
Sep 26 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 19.26 | 278 | 5,355 | 11,327 |
Sep 26 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 19.26 | 406 | 7,821 | 16,538 |
Sep 26 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 19.26 | 40,562 | 781,386 | 1,654,114 |
Sep 26 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 18.99 | 699 | 13,273 | 31,536 |
Sep 26 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 18.99 | 245 | 4,652 | 11,082 |
Sep 26 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 18.99 | 359 | 6,817 | 16,179 |
Sep 26 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 18.99 | 35,872 | 681,141 | 1,618,242 |
Sep 22 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 20.03 | 801 | 16,042 | 34,992 |
Sep 22 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 20.03 | 282 | 5,648 | 12,295 |
Sep 22 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 20.03 | 411 | 8,232 | 17,953 |
Sep 22 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 20.03 | 41,116 | 823,467 | 1,795,587 |
Sep 22 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 19.86 | 1,967 | 39,063 | 33,025 |
Sep 22 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 19.86 | 690 | 13,703 | 11,605 |
Sep 22 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 19.86 | 1,009 | 20,038 | 16,944 |
Sep 22 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Sell | 19.86 | 100,911 | 2,004,022 | 1,694,676 |
Jun 20 2017 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 17.47 | 6,410 | 111,983 | 6,410 |
Jun 12 2017 | SYRS | Syros Pharmaceuticals, In ... | Nashat Amir | Director | Option Exercise | 14.26 | 11,000 | 156,860 | 11,000 |
May 11 2017 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | 3.15 | 20,000 | 63,000 | 20,000 |
May 04 2017 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Option Exercise | 4.73 | 25,000 | 118,250 | 25,000 |
Sep 19 2016 | SYRS | Syros Pharmaceuticals, In ... | Nashat Amir | Director | Option Exercise | 12.59 | 22,000 | 276,980 | 22,000 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Nashat Amir | Director | Buy | 0.00 | 1,164,486 | 0 | 1,164,486 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Nashat Amir | Director | Buy | 0.00 | 22,167 | 0 | 22,167 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Nashat Amir | Director | Buy | 12.50 | 373,847 | 4,673,088 | 1,538,333 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Nashat Amir | Director | Buy | 12.50 | 26,153 | 326,913 | 48,320 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Nashat Amir | Director | Option Exercise | 0.00 | 4,366,825 | 0 | 0 |
Jul 07 2016 | SYRS | Syros Pharmaceuticals, In ... | Nashat Amir | Director | Option Exercise | 0.00 | 83,129 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Buy | 0.00 | 32,207 | 0 | 32,972 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Buy | 0.00 | 11,318 | 0 | 11,586 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Buy | 0.00 | 16,524 | 0 | 16,916 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Buy | 0.00 | 1,652,646 | 0 | 1,691,963 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Buy | 14.00 | 2,821 | 39,494 | 35,793 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Buy | 14.00 | 991 | 13,874 | 12,577 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Buy | 14.00 | 1,448 | 20,272 | 18,364 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Buy | 14.00 | 144,740 | 2,026,360 | 1,836,703 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 6,494 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 2,282 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 3,332 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 333,207 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 11,875 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 4,174 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 6,093 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 609,316 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 4,420 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 1,553 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 2,267 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 226,801 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 4,647 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 1,632 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 2,384 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 238,470 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 3,078 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 1,082 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 1,579 | 0 | 0 |
Jun 29 2016 | SELB | SELECTA BIOSCIENCES INC | Nashat Amir | Director | Option Exercise | 0.00 | 157,957 | 0 | 0 |
May 26 2016 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | 3.33 | 18,000 | 59,940 | 18,000 |
May 13 2016 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Option Exercise | 1.69 | 25,000 | 42,250 | 25,000 |
Jan 29 2016 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | 6.14 | 19,428 | 119,288 | 19,428 |
Jul 10 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Option Exercise | 14.96 | 6,286 | 94,039 | 6,286 |
Jun 10 2015 | BIND | BIND Therapeutics, Inc | Nashat Amir | Director | Option Exercise | 5.87 | 15,000 | 88,050 | 15,000 |
May 15 2015 | FATE | FATE THERAPEUTICS INC | Nashat Amir | Director | Option Exercise | 7.08 | 10,000 | 70,800 | 10,000 |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Buy | 0.00 | 1,674,825 | 0 | 1,674,825 |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Buy | 0.00 | 32,642 | 0 | 32,642 |
May 14 2015 | LIFE | aTYR PHARMA INC | Nashat Amir | Director | Buy | 0.00 | 11,472 | 0 | 11,472 |